Advanced search×

Unconventional remedies used for patients with juvenile arthritis.

T R Southwood, P N Malleson, P J Roberts-Thomson, and M Mahy

Pediatrics 85(2):150-4 (1990) PMID 2296502

While attending arthritis youth camps, 53 patients with juvenile arthritis from Australia (31 patients), New Zealand (4 patients), and Canada (18 patients) completed individual questionnaires concerning their treatment. Between 1 and 8 unconventional remedies (mean 2.6) had been used by 37 (70%) of the patients. The most commonly used unconventional remedies were copper bracelets (68%), diet (43%), and patent medicines (38%). The potential dangers of unconventional remedy use in children are illustrated by three case reports. Professionals caring for patients with juvenile arthritis should be aware that most of them will probably use unconventional remedies at some time.

Version: za2963e q8zae q8zbe q8zc8 q8zd2 q8ze6 q8zf2 q8zgb

Similar articles you may find interesting…

  1. Frequency, Characteristics and Management of Adolescent Inpatient Aggression.
    Immaculada Baeza, Christoph U Correll, and Maren Carbon

    J Child Adolesc Psychopharmacol (2013) PMID 23647136

    Despite high rates of pharmacological interventions, SRU continue to be used in adolescent inpatient care. As both of these approaches lack a clear evidence base, and as adolescents with clinically significant inpatient aggression have increased illness acuity/severity and service needs, structured...
  2. Diagnostic accuracy of preoperative alpha-fetoprotein as an ovarian tumor marker in children and adolescents: not as good as we thought?
    Amos Hong Pheng Loh, Kelvin Wai Cheak Gee, and Joyce Horng Yiing Chua

    Pediatr Surg Int (2013) PMID 23653236

    Twenty patients (18.2 %) had non-benign ovarian neoplasms, of which 12 had GCT/IT (10.9 %). In diagnosing GCT/IT versus non-GCT/IT, specificity of preoperative serum AFP was 87.8 %, sensitivity 66.7 %, and AUC 0.853. Excluding infants to remove the effects of increased variance in AFP in this gr...
  3. Serum Interleukin 6 Before and After Therapy with Tocilizumab Is a Principal Biomarker in Patients with Rheumatoid Arthritis.
    Keiko Shimamoto, Tomoki Ito, and Shosaku Nomura

    Journal Watch (General) (2013) PMID 23637318

    Although IL-1β, IL-2, IL-6, IL-17A, IL-17F, interferon-α, and tumor necrosis factor-α (TNF-α) were all increased in sera from patients with RA compared with controls, only the IL-6 level was significantly correlated with DAS28 before treatment. The IL-6 level before treatment was positively corr...